
Validea's Growth Investor model, based on Martin Zweig's strategy, assigned Synopsys (SNPS) a 46% rating, falling significantly below the 80% threshold for investor interest. While the large-cap software firm demonstrated strong sales growth, earnings persistence, long-term EPS growth, and low debt, it notably failed key criteria related to P/E ratio, earnings growth acceleration, and consistency, indicating it does not align with the model's preference for rapidly accelerating, reasonably valued growth stocks.
Based on Validea's fundamental report, Synopsys (SNPS) does not align with the criteria of the Martin Zweig-based Growth Investor model, scoring a notably low 46% where a score above 80% is typically required to indicate interest. The analysis reveals a significant divergence in the company's performance metrics. While SNPS passes on several foundational criteria, including its sales growth rate, long-term EPS growth, earnings persistence, and a healthy balance sheet indicated by a low debt/equity ratio, it critically fails on metrics central to the Zweig strategy. The model flags a 'FAIL' on the P/E ratio, suggesting valuation concerns. More importantly, SNPS fails seven distinct tests related to earnings momentum and acceleration, including positive earnings growth for the current quarter and the rate of EPS growth compared to prior quarters and its own historical trend. This indicates that despite underlying sales growth, the company lacks the accelerating profitability and earnings momentum that this specific growth-oriented strategy prioritizes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment